Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Akanda Corp.

Akanda Corp. (AKAN) Stock Overview

Explore Akanda Corp.’s financial performance, market position, analyst ratings, and future outlook.

AKAN●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$1.08
$0.04(3.57%)
U.S. Market opens in 6h 9m

Akanda Corp. (AKAN)

Meyka AI Score

Z

Key Financials

Market Cap2.6M
P/E Ratio-0.00
EPS (TTM)$-44.79
ROE3.92%
Fundamental Analysis

AI Price Forecasts

1 Month$1.19
3 Months$5.64
1 Year Target$0.00

AKAN Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Akanda Corp. (NASDAQ: AKAN) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Akanda Corp.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of AKAN on the NASDAQ shows an RSI of 17.93, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Akanda Corp.'s NASDAQ-traded stock include a P/E ratio of -0.00 and a market capitalization of 2.6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of AKAN on the NASDAQ.

Price Performance (NASDAQ: AKAN)

1-Day Change
-3.57%
5-Day Change
-20.59%
1-Month Change
-66.46%
3-Month Change
-87.69%
6-Month Change
-68.42%
Year-to-Date (YTD) Change
-88.21%
1-Year Change
-97.56%
3-Year Change
-99.96%
5-Year Change
-100.00%
All-Time (Max) Change
-100.00%

Contact Information

https://www.akandacorp.com
44 20 3488 9514
100 King St. W, Toronto, ON, M5X 1G5

Company Facts

80 Employees
IPO DateMar 15, 2022
CountryCA
Actively Trading

Frequently Asked Questions